Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Fosfomycin + metronidazole by Reponex Pharmaceuticals for Colon Cancer: Likelihood of Approval
Fosfomycin + metronidazole is under clinical development by Reponex Pharmaceuticals and currently in Phase II for Colon Cancer. According to...